Journal
ONCOIMMUNOLOGY
Volume 2, Issue 8, Pages -Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/onci.25156
Keywords
regulatory T cells; VEGF-A; proliferation; immunosuppression; tumor; colorectal cancer
Categories
Ask authors/readers for more resources
Some of the anti-angiogenic agents currently used to treat solid malignancies have effects on tumor endothelial cells as well as on immune cells. we have recently demonstrated that targeting the vascular endothelial growth factor A (VEGFA)/VEGF receptor 2 (VEGFR2) signaling pathway reduces the proportion of regulatory T cells (Treg) in a mouse model of colorectal cancer (CRC) and in metastatic CRC patients as it inhibits tumor-induced Treg proliferation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available